Investment Thesis
Nextel Medical is in severe financial distress with zero revenue, negative stockholders' equity of -$463.3K, and minimal assets of $1.0K against liabilities of $464.3K. The company is technically insolvent with negative operating cash flow and no discernible business operations, representing an extreme risk of total loss.
Strengths
Risks
- Zero revenue and no operational business activity
- Negative stockholders' equity indicating technical insolvency
- Liabilities exceed assets by $463.3K with minimal cash runway
- Negative operating cash flow of -$61.3K with no ability to fund operations
- Negligible asset base of $1.0K provides no liquidation value protection
- Data is stale as of July 31, 2020 with no recent insider activity indicating abandonment
Key Metrics to Watch
- Return to positive revenue or business activity
- Debt restructuring or capital injection
- Total asset value trend
Financial Metrics
Revenue
0.0
Net Income
-76.7K
EPS (Diluted)
$0.00
Free Cash Flow
-61.3K
Total Assets
1.0K
Cash
0.0
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
N/A
ROA
-7,674.2%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
0.00x
Quick Ratio
0.00x
Debt/Equity
N/A
Debt/Assets
46,425.3%
Interest Coverage
-134.15x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-01T12:40:09.314057 |
Data as of: 2020-07-31 |
Powered by Claude AI